SOLENO THERAPEUTICS INC Shareholders' Equity
SOLENO THERAPEUTICS INC had Shareholders' Equity of $495.80 million as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-05-07
- 2026-03-31: Stockholders' Equity Attributable to Parent $495.80M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $450.12M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $494.81M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $240.14M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-03-31 | $495.80M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $450.12M 10-Q · filed 2026-05-07 | |
| 2025-09-30 | $494.81M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $240.14M 10-Q · filed 2025-11-04 | |
| 2025-03-31 | $232.26M 10-Q · filed 2026-05-07 | |
| 2024-12-31 | $245.11M 10-Q · filed 2026-05-07 | |
| 2024-09-30 | $264.70M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $280.76M 10-Q · filed 2025-11-04 | |
| 2024-03-31 | $143.39M 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $157.51M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $23.22M 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $12.43M 10-Q · filed 2024-11-06 | |
| 2023-03-31 | $2.64M 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $10.35M 10-K · filed 2026-02-25 | |
| 2022-09-30 | $15.20M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $20.31M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $26.46M 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $17.79M 10-K · filed 2025-02-28 | |
| 2021-09-30 | $20.20M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $27.44M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $37.57M 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $45.55M 10-K · filed 2023-03-22 | |
| 2020-09-30 | $48.01M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $56.18M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $9.48M 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $14.95M 10-K · filed 2022-03-31 | |
| 2019-09-30 | $14.88M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $13.84M 10-Q · filed 2020-11-10 | |
| 2019-03-31 | $23.63M 10-Q · filed 2020-11-10 | |
| 2018-12-31 | $30.41M 10-K · filed 2021-03-03 | |
| 2018-09-30 | $14.21M 10-Q/A · filed 2019-11-18 | |
| 2018-06-30 | $16.65M 10-Q/A · filed 2019-11-18 | $15.84M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $23.25M 10-Q/A · filed 2019-11-18 | $23.02M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $26.82M 10-K · filed 2020-03-04 | $26.53M 10-K · filed 2018-04-02 |
| 2017-09-30 | $23.21M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $26.69M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $30.14M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $3.44M 10-K · filed 2019-03-20 | $3.44M 10-K · filed 2017-03-15 |
| 2016-09-30 | $5.71M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $2.61M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $5.83M 10-Q · filed 2016-08-09 | |
| 2015-12-31 | $3.22M 10-K · filed 2018-04-02 | |
| 2015-09-30 | -$1.29M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | -$7.63M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | -$11.30M 10-Q · filed 2015-05-04 | |
| 2014-12-31 | -$11.19M 10-K · filed 2017-03-15 | -$10.33M 10-K · filed 2015-03-13 |
| 2014-09-30 | -$42.38M 10-Q · filed 2014-12-18 | |
| 2013-12-31 | -$34.20M 10-K · filed 2016-03-25 | -$37.86M 10-Q · filed 2014-12-18 |
| 2012-12-31 | -$34.20M 10-K · filed 2015-03-13 |